alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 74, Number 98 (Friday, May 22, 2009)]
[Notices]
[Pages 24051-24052]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-11978]


-----------------------------------------------------------------------

SMALL BUSINESS ADMINISTRATION

[Disaster Declaration <greek-i> 11754 and <greek-i> 11755]


Tennessee Disaster <greek-i>TN-00027

AGENCY: U.S. Small Business Administration.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This is a Notice of the Presidential declaration of a major 
disaster for Public Assistance Only for

[[Page 24052]]

the State of Tennessee (FEMA-1839-DR), dated 05/15/2009.
    Incident: Severe storms, tornadoes, and flooding.
    Incident Period: 04/10/2009.
    Effective Date: 05/15/2009.
    Physical Loan Application Deadline Date: 07/14/2009.
    Economic Injury (EIDL) Loan Application Deadline Date: 02/15/2010.

ADDRESSES: Submit completed loan applications to: U.S. Small Business 
Administration, Processing and Disbursement Center, 14925 Kingsport 
Road, Fort Worth, TX 76155.

FOR FURTHER INFORMATION CONTACT: A. Escobar, Office of Disaster 
Assistance, U.S. Small Business Administration, 409 3rd Street, SW., 
Suite 6050, Washington, DC 20416.

SUPPLEMENTARY INFORMATION: Notice is hereby given that as a result of 
the President's major disaster declaration on 05/15/2009, Private Non-
Profit organizations that provide essential services of governmental 
nature may file disaster loan applications at the address listed above 
or other locally announced locations.
    The following areas have been determined to be adversely affected 
by the disaster:

Primary Counties:
    Benton, McMinn, Rutherford, Sequatchie.
    The Interest Rates are:

------------------------------------------------------------------------
                                                                Percent
------------------------------------------------------------------------
    Other (Including Non-Profit Organizations) With Credit        4.500.
     Available Elsewhere.....................................
    Businesses and Non-Profit Organizations Without Credit        4.000.
     Available Elsewhere.....................................
------------------------------------------------------------------------

    The number assigned to this disaster for physical damage is 11754B 
and for economic injury is 11755B.

(Catalog of Federal Domestic Assistance Numbers 59002 and 59008)

Roger B. Garland,
Acting Associate Administrator for Disaster Assistance.
[FR Doc. E9-11978 Filed 5-21-09; 8:45 am]
BILLING CODE 8025-01-P
<!DOCTYPE html>
<html>
<head>
    <meta name="viewport" content="width=device-width" />
    <meta name="robots" content="noindex">
    <title>Jobs at NIDDK - NIDDK</title>
    
<meta name="VIcurrentDateTime" content="638490780489802673" />
<meta name="VirtualFolder" content="/" />
<script type="text/javascript" src="/layouts/system/VisitorIdentification.js"></script>

</head>
<body>
    <div></div>
</body>
</html>
EXHIBIT 32.1

                                  CERTIFICATION
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of QuantRx  Biomedical  Corporation (the
"Company") on Form 10-QSB for the period ending March 31, 2006 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"),  I, Walter
Witoshkin,  Chief  Executive  Officer of the  Company,  certify,  pursuant to 18
U.S.C. ss.1350, as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002,
that to my knowledge:

1. the Report fully complies with the  requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

2. the  information  contained in the Report  fairly  presents,  in all material
respects, the financial condition and results of operations of the Company.


                                                  /s/ Walter Witoshkin
                                                  ------------------------------
                                                  Walter Witoshkin,
                                                  Chief Executive Officer

Date: November 29, 2006

A signed  original of this  written  statement  required by Section 906 has been
provided to the Company and will be retained by the Company and furnished to the
Securities and Exchange Commission or its staff upon request.
##### 



Exhibit 32.2
 Written Statement of Vice Chairman and Chief Financial Officer
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)
  (a)
    
    the Quarterly Report on Form 10-Q/A of the Company for the Quarter Ended June
30, 2006 filed on the date hereof with the Securities and Exchange Commission (the
Report) fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and(b)
    
    information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
 /s/ Garrett E. PierceGarrett E. PierceVice Chairman and Chief Financial OfficerDecember 7, 2006
```

[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 976 Referred in House (RFH)]

  1st Session
                                 S. 976

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 2, 2005

            Referred to the Committee on Energy and Commerce

_______________________________________________________________________

                                 AN ACT

 
  Striking the Specific Privatization Criteria in ORBIT for Intelsat 
    Separated Entities (New Skies) and Inmarsat and Other Technical 
                              Corrections.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SPECIFIC CRITERIA FOR INTELSAT SEPARATED ENTITIES AND 
              INMARSAT MODIFIED.

    (a) Amendment.--The Communications Satellite Act of 1962 (47 U.S.C. 
701 et seq.) is amended--
            (1) by striking section 623 (47 U.S.C. 763b), and
            (2) in section 624 (47 U.S.C. 763c), by striking ``In 
        securing the privatizations'' and all that follows, and 
        inserting ``In securing the privatization of Inmarsat required 
        by section 621, and thereafter, the United States shall 
        preserve space segment capacity of the GMDSS.''
            (3) in section 621 (5)(D)(ii) (47 U.S.C. 763), by striking 
        ``(I)'' and by striking ``, or (II) have any direct financial 
        interest'' and all that follows through the end of the 
        subparagraph, and inserting ``;''.
            (4) in section 621 (5)(D)(iv) (47 U.S.C. 763), by striking 
        ``(I)'' and by striking ``, or (II) have any direct financial 
        interest'' and all that follows through the end of the 
        subparagraph, and inserting ``.''.
    (b) Satellite Service Report.--The Commission shall review 
competitive market conditions with respect to domestic and 
international satellite communications services and shall include in an 
annual report an analysis of those conditions. Such analysis shall 
include an identification of the number and market share of competitors 
in domestic and international satellite markets, including an analysis 
of whether there is effective competition in the market for domestic 
and international satellite services, and shall include a list of any 
foreign nations in which legal or regulatory practices restrict access 
to the market for satellite services in such nation in a manner that 
undermines competition or favors a particular competitor or set of 
competitors.
    (c) Effective Date.--The amendments made by subsection (a) shall be 
effective as of the date of enactment of this section.

            Passed the Senate April 29 (legislative day, April 28), 
      2005.

            Attest:

                                             EMILY J. REYNOLDS,

                                                             Secretary.
```
[Federal Register Volume 74, Number 100 (Wednesday, May 27, 2009)]
[Notices]
[Pages 25262-25263]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-12234]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Dental & Craniofacial Research; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Dental and Craniofacial 
Research Special Emphasis Panel; ZDE1 VH (31) Review of OD-09-058 
Competitive Revisions R01 and R21 applications.
    Date: June 15, 2009.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, One Democracy Plaza, 6701 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Victor Henriquez, PhD, Scientific Review 
Officer, DEA/SRB/NIDCR, 6701 Democracy Blvd., Room 668, Bethesda, MD 
20892-4878, 301-451-2405, <a href="/cdn-cgi/l/email-protection#6109040f1308101417210f080502134f0f08094f060e17"><span class="__cf_email__" data-cfemail="88e0ede6fae1f9fdfec8e6e1ecebfaa6e6e1e0a6efe7fe">[email protected]</span></a>.

    Name of Committee: National Institute of Dental and Craniofacial 
Research Special Emphasis Panel; ZDE1 VH (26) Review of R03 and R21 
Applications on Osteonecrosis of the Jaw (ONJ).
    Date: June 22, 2009.
    Time: 1 p.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, One Democracy Plaza, 6701 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Victor Henriquez, PhD, Scientific Review 
Officer, DEA/SRB/NIDCR, 6701 Democracy Blvd., Room 668, Bethesda, MD 
20892-4878, 301-451-2405, <a href="/cdn-cgi/l/email-protection#a5cdc0cbd7ccd4d0d3e5cbccc1c6d78bcbcccd8bc2cad3"><span class="__cf_email__" data-cfemail="b7dfd2d9c5dec6c2c1f7d9ded3d4c599d9dedf99d0d8c1">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral 
Diseases and

[[Page 25263]]

Disorders Research, National Institutes of Health, HHS)

    Dated: May 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-12234 Filed 5-26-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
**Exhibit 32.1**

 

**CERTIFICATION OFCHIEF EXECUTIVE OFFICER**

** **

 

I, Kenneth R. Posner, Presidentand Chief Executive Officer, in connection with the Report on Form 10-Q ofAngelo and Maxie’s, Inc. for the quarterly period ended June 30, 2003, herebycertify in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906of the Sarbanes-Oxley Act of 2002, that:

 

1)     The accompanying Report of Angelo andMaxie’s, Inc. on Form 10-Q for the quarterly period ended June 30, 2003 fullycomplies with the requirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934  and

2)     The information contained in such Reportfairly presents, in all material respects, the financial condition and resultsof operations of Angelo and Maxie’s, Inc.

 

 
|   | /s/ KENNETH  R. POSNER                 |   |   |
|--------|----------------------------------------|--------|--------|
|   | Kenneth R.  Posner                     |   |
|   | President  and Chief Executive Officer |   |
|   | Date:  August 13, 2003            |   |

 

 

A signedoriginal of this written statement required by Section 906 has been provided toAngelo and Maxie’s, Inc. and will be retained by Angelo and Maxie’s, Inc. andfurnished to the Securities and Exchange Commission or its staff upon request.

 

1

----
**Exhibit 15.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We consent to the incorporation by reference in the Registration Statement No. 333-207389 on Form F-3 of our report dated April 20, 2016, relatingto the consolidated financial statements of Banco Santander, S.A. (the “Bank”) and Companies composing, together with the Bank, the Santander Group (the “Group”), and our report dated April 20, 2016, relating to theeffectiveness of the Group’s internal control over financial reporting, appearing in this Annual Report on Form 20-F of the Group for the year ended December 31, 2015. 

/s/ Deloitte, S.L. 

DELOITTE, S.L. 

Madrid, Spain 

April 20, 2016
#### SUTHERLAND PAPER CO. v. GRANT PAPER BOX CO. et al.

Civ. A. No. 6013.

District Court, W. D. Pennsylvania.

June 24, 1947.

See, also, 7 F.R.D. 358.

Rose, Eichenauer, Stewart & Lewis and T. W. Pomeroy, Jr., all of Pittsburgh, Pa., for plaintiff.

Christy, Parmelee & Strickland, of Pittsburgh, Pa., for defendants.

GIBSON, District Judge.

By the plaintiff’s action a declaratory judgment is sought by which defendant’s Patent No. 2,031,036 is held to be invalid or not infringed by plaintiff.

The defendant, Grant Paper Box Company, has filed two motions, one under Rule 12(c) of the Rules of Civil Procedure, 28 U. S.C.A. following section 723c, for judgment on the pleadings on the ground that the complaint fails to state a claim upon which relief can be granted, and the other under Rule 42(b) for a separate trial upon issites set forth in paragraph 13 of defendant’s answer to plaintiff’s bill and certain paragraphs of its counterclaim.

As to the motion first mentioned, the requirements of the Federal Rules for Civil Procedure are by no means rigid in respect to the allegations in a complaint. While defendant criticizes the complaint, it relies more upon subject matter set forth in the answer and counterclaim. Such matter does not properly attack the complaint as such. From the standpoint of form it seems to be quite sufficient as a pleading under the Rules.

The second motion in effect alleges that the plaintiff was a licensee under defend*358ant’s patent, and also was bound by its verbal contract with defendant by which the latter, at plaintiff’s request, brought an action in the First Circuit against the Russell Box Company for infringement of the Patent No. 2,031,036, in which the patent was held to be valid and infringed. Under these circumstances defendant asserts that plaintiff is estopped from proceeding in the instant action, and asks that this matter of estoppel be tried apart from the issues of validity and infringement.

Such action would seem desirable if it were not for the pleading that the price-fixing provision of the license and agreement is in violation of the AntLTrust laws of the United States. With' such an allegation in the answer to the counterclaim the plaintiff cannot be precluded from testing the validity of the patents. See Sola Electric Co. v. Jefferson Electric Co. 317 U.S. 173, 63 S.Ct. 172, 87 L.Ed. 165; Katsinger Co. v. Chicago Mfg. Co., 329 U.S. 394, 67 S.Ct. 416, 424; MacGregor v. Westinghouse Electric & Manufacturing Co., 329 U.S. 402, 67 S.Ct. 421, 424.

Both of the motions mentioned supra must be denied.
## Breadcrumb

-  Home 
-  News & Events 

# NIDCD Calendar of Events

NIDCD Staff Presentations at AChemS Annual Meeting

NIDCD Seminar Series: Alain Dabdoub, Ph.D.
Alain Dabdoub, Ph.D., University of Toronto

NDCD Advisory Council Meeting: May 2024

NIDCD Seminar Series: Martha Bagnall, Ph.D.
Martha Bagnall, Ph.D., Washington University in St. Louis

NIDCD Seminar Series: Elisabeth Glowatzki, Ph.D.
Elisabeth Glowatzki, Ph.D., Johns Hopkins University

Zebrafish Can Help Us “See” How Hearing Works
Katie Kindt, Ph.D., Senior Investigator, National Institute on Deafness and Other Communication Disorders

EARssentials: Concepts and Techniques of Contemporary Hearing Research 2024

NDCD Advisory Council Meeting: September 2024

NDCD Advisory Council Meeting: January 2025

NDCD Advisory Council Meeting: May 2025

#### Pagination

-                Current page            1 
-                Page            2 
-  Next pageNext › 
-  Last pageLast » 

View previous NIDCD events

## Event Series: More Information

            - Beyond the Lab, Understanding Communication Disorders: Speaker Series
            - EARssentials: Concepts and Techniques of Contemporary Hearing Research
            - National Deafness and Other Communication Disorders Advisory Council (NDCD) Meetings
            - NIDCD Director’s Seminar Series: Advancing the Science of Communication to Improve Lives
            - NIDCD Seminar Series
            - NIDCD Staff Presentations at Non-NIH Events
            - Robert J. Wenthold Memorial Lectures
            - Training Webinars
NUMBER 13-18-00366-CV

COURT OF APPEALS

THIRTEENTH DISTRICT OF TEXAS

CORPUS CHRISTI - EDINBURG

LEONARD ALVAREZ, INDIVIDUALLY, APPELLANT,

AND AS NEXT FRIEND OF CASEY 

ALVAREZ, MINOR CHILD,

v.

BROOKE R. SALAZAR-DAVIS, 

INDIVIDUALLY AND IKE DAVIS JR., 

INDIVIDUALLY, AND AS NEXT FRIEND 

OF GABRIEL DAVIS, MINOR CHILD, APPELLEES.

On appeal from the 24th District Court

of Victoria County, Texas.

ORDER ABATING APPEAL

Before Chief Justice Valdez and Justices Rodriguez and Benavides

Order Per Curiam

Currently before the Court is appellant’s opposed motion to abate premature 

appeal. Appellant states the motion for summary judgment granted on April 24, 2018 
2

did not dispose of all claims and is not final and appealable. Appellant has filed a motion 

with the trial court to sever and abate the remaining claim against appellees and a hearing 

on the motion is scheduled for September 11, 2018. 

Texas Rule of Appellate Procedure 27.2 provides that appellate courts “may allow 

an appealed order that is not final to be modified so as to be made final and may allow 

the modified order and all proceedings relating to it to be included in a supplemental 

record.” TEX. R. APP. P. 27.1. Accordingly, we grant appellant’s motion and ABATE the 

appeal. Appellant shall, within 60 days after the date of this order, take action to cure 

the jurisdictional defect and to file a supplemental clerk's record containing a severance 

of the remaining claims against appellees. If such supplemental clerk's record is not filed 

in this Court, we will dismiss the appeal for want of jurisdiction. See TEX. R. APP. P. 42.3. 

It is so ORDERED.

PER CURIAM

Delivered and filed the

4th day of September, 2018.
[Federal Register Volume 74, Number 100 (Wednesday, May 27, 2009)]
[Notices]
[Page 25250]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-12209]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Eunice Kennedy Shriver National Institute of Child Health & Human 
Development; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Child Health and Human 
Development Initial Review Group. Pediatrics Subcommittee.
    Date: June 18, 2009.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: The Legacy, 1775 Rockville Pike, Rockville, MD.
    Contact Person: Rita Anand, PhD, Scientific Review 
Administrator, Division of Scientific Review, National Institute of 
Child Health, and Human Development, NIH, 6100 Executive Blvd Room 
5B01, Bethesda, MD 20892. (301) 496-1487. <a href="/cdn-cgi/l/email-protection#83e2ede2ede7f1c3eee2eaefadedeaebade4ecf5"><span class="__cf_email__" data-cfemail="debfb0bfb0baac9eb3bfb7b2f0b0b7b6f0b9b1a8">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, 
Population Research; 93.865, Research for Mothers and Children; 
93.929, Center for Medical Rehabilitation Research; 93.209, 
Contraception and Infertility Loan Repayment Program, National 
Institutes of Health, HHS)

    Dated: May 18, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-12209 Filed 5-26-09; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 23


                         CONSENT OF INDEPENDENT AUDITORS

         We consent to the incorporation by reference in the Registration
Statements on Form S-8 (File No.'s 333-107561 and 333-35708) of GelStat
Corporation and Subsidiary (a development stage company) (formerly known as
Developed Technology Resources, Inc.) of our report dated March 18, 2004, which
appears on page 24 of this annual report on Form 10-KSB for the year ended
December 31, 2003.


                                              /s/ VIRCHOW, KRAUSE & COMPANY, LLP

Minneapolis, Minnesota
March 30, 2004